Bone marrow characterization in sickle cell disease: inflammation and stress erythropoiesis lead to suboptimal CD34 recoveryAlexis Leonard, John F. Tisdale, Francis J. Pierciey et al.|British Journal of Haematology|2019Cited by 75
BCL11A enhancer–edited hematopoietic stem cells persist in rhesus monkeys without toxicitySelami Demirci, John F. Tisdale, Allen E. Krouse et al.|Journal of Clinical Investigation|2020Cited by 67
CRISPR/Cas9 for Sickle Cell Disease: Applications, Future Possibilities, and ChallengesSelami Demirci, John F. Tisdale, Alexis Leonard et al.|Advances in experimental medicine and biology|2019Cited by 62
Cas9 protein delivery non-integrating lentiviral vectors for gene correction in sickle cell diseaseNaoya Uchida, John F. Tisdale, Julia DiNicola et al.|Molecular Therapy — Methods & Clinical Development|2021Cited by 51
High-Efficiency Lentiviral Transduction of Human CD34+ Cells in High-Density Culture with Poloxamer and Prostaglandin E2Naoya Uchida, John F. Tisdale, Jackson Gamer et al.|Molecular Therapy — Methods & Clinical Development|2019Cited by 47